Conversis Medical hires global director
June 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing conversis, hooper, medical
Medical translation agency Conversis Medical has appointed Dr Mark Hooper as its global director. Hooper has worked in the pharma …
Boehringer abandons hep C
June 23, 2014Research and Development, Sales and Marketing AbbVie, Boehringer, HCV, faldaprevir, german, hep C
Boehringer Ingelheim has abandoned its hepatitis C (HCV) drug development programme as a dead loss after ‘re-evaluating’ its strategy. The …
Lilly’s Efient tipped for expanded NICE approval
June 20, 2014Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner
Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …
Dr Reddy’s recalls blood pressure drug
June 20, 2014Manufacturing and Production Dr Reddy's, India, blood pressure, metoprolol succinate, recall, toprol
Indian generics manufacturer Dr Reddy’s Laboratories is in the midst of recalling more than 13,000 bottles of blood pressure medicine …
PAN expands creative team with two hires
June 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ogilvy, Pan
Creative agency PAN has increased its team by hiring two new people in Minas Maroudas (pictured) who joins as senior …
Dementia research ‘achingly slow’
June 20, 2014Research and Development, Sales and Marketing Alzheimer's, Cameron, Parkinson's, Parkinsons, UK, billings, dementia, research
The UK prime minister’s envoy on dementia has described progress on research into the neurodegenerative condition as ‘achingly slow’. Global …
AbbVie moves in on Shire with $46 billion bid
June 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger
AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …
Novartis emphasises pharma growth
June 19, 2014Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory
Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …
Teva chairman stepping down amid revamp
June 19, 2014Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma
Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …
Valeant goes hostile over Allergan hunt
June 19, 2014Sales and Marketing Allergan, Botox, Valeant, hostile, takeover
Valeant Pharmaceuticals has turned hostile in its bid to acquire Botox maker Allergan by employing strong-arm tactics in an attempt …
£16m dementia research platform launched
June 19, 2014Research and Development, Sales and Marketing Alzheimer's, MRC, Parkinson's, brain, dementia, ukdp
The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up …
Bartlett hires account manager
June 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dominique Pizzingrilli, bartlett Davis Communications
Bartlett Davis Communications has welcomed Dominique Pizzingrilli to the newly-created role of account manager. Pizzingrilli takes a wealth of healthcare …
AbbVie hep C treatment fast-tracked
June 18, 2014Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi
The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …
FDA publishes ‘new thinking’ on social media use
June 18, 2014Medical Communications, Sales and Marketing ABPI, FDA, Facebook, Twitter, social media
The FDA has issued new draft guidance on how pharmaceutical and medical device firms in the US can talk about …
Genome-driven lung cancer trial launches
June 18, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Genentech, MedImmune, Pfizer, genome, lung cancer
Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …
Amgen lures senior head from 3M
June 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amgen 3m, david meline
Amgen has poached David Meline from US multinational firm 3M to serve as an executive VP and chief financial officer. …
Teva to close half its sites
June 17, 2014Manufacturing and Production, Sales and Marketing Jobs, Teva, cuts, generics, manufacturing
Teva Pharmaceutical Industries is to close around half of its 75 manufacturing sites within the next five years, chief financial …
ABPI president: NICE needs political reform
June 17, 2014Business Services, Medical Communications, Research and Development ABPI, NHS, NICE, Pfizer, QALY, emms, jonathan, vba
NICE needs to be reformed with its QALY formula heavily revised if it is to meet the challenges of 21st …
Pfizer opens R&D hub in US Cambridge
June 17, 2014Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, Massachusetts, Pfizer, kit, manufacturing, research
Pfizer has open a new 280,000 sq.ft. R&D hub in Cambridge, Massachusetts which also serves to bring together 1,000 of …
Knighthoods for Blakemore and Francis
June 17, 2014Medical Communications, Sales and Marketing Francis, Mid Staffs, NHS, blakemore, mdc, queen
Two key figures in healthcare research and reform received knighthoods in the Queen’s Birthday Honours. Professor Colin Blakemore, former head …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
